Clinical Trial Update: A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for ABF-101 in single- and multiple-ascending dose cohorts is underway. The study targets age-related macular degeneration and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• ABF-101

Snippet

Sponsor: Aptabio Therapeutics, Inc. | Conditions: Age Related Macular Degeneration (ARMD), AMD - Age-Related Macular Degeneration | Phase 1 | Status: RECRUITING